These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 7627262)

  • 21. Changes in parathyroid hormone receptor binding affinity during egg laying: implications for calcium homeostasis in chicken.
    Yasuoka T; Kawashima M; Takahashi T; Iwata A; Oka N; Tanaka K
    J Bone Miner Res; 1996 Dec; 11(12):1913-20. PubMed ID: 8970893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distribution of vasoactive intestinal polypeptide binding sites in guinea pig genital tissues.
    Inyama CO; Wharton J; Davis CJ; Jackson RH; Bloom SR; Polak JM
    Neurosci Lett; 1987 Oct; 81(1-2):111-6. PubMed ID: 2827063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vasoactive intestinal peptide receptors in brains of hepatic encephalopathy rats. An experimental study.
    Zhang Z; Qiu F
    Chin Med J (Engl); 1995 May; 108(5):328-31. PubMed ID: 7555231
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sex differences in vasoactive intestinal peptide (VIP) concentrations in the anterior pituitary and hypothalamus of rats.
    Riskind PN; Allen JM; Gabriel SM; Koenig JI; Audet-Arnold J
    Neurosci Lett; 1989 Oct; 105(1-2):215-20. PubMed ID: 2485881
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of mitogen-stimulated proliferation of murine splenocytes by a novel neuropeptide, pituitary adenylate cyclase activating polypeptide: a comparative study with vasoactive intestinal peptide.
    Tatsuno I; Gottschall PE; Arimura A
    Endocrinology; 1991 Feb; 128(2):728-34. PubMed ID: 1989859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Receptors for vasoactive intestinal peptide in rat anterior pituitary glands: localization of binding to lactotropes.
    Wanke IE; Rorstad OP
    Endocrinology; 1990 Apr; 126(4):1981-8. PubMed ID: 2156675
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Vasoactive intestinal peptide receptors in the brains of hepatic encephalopathy rats].
    Zhang ZM; Qiu FZ; Chen XP
    Zhonghua Yi Xue Za Zhi; 1994 Apr; 74(4):238-40, 256. PubMed ID: 7922767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Localization and developmental pattern of vasoactive intestinal polypeptide binding sites in the human hypothalamus.
    Sarrieau A; Najimi M; Chigr F; Kopp N; Jordan D; Rostene W
    Synapse; 1994 Jun; 17(2):129-40. PubMed ID: 8091302
    [TBL] [Abstract][Full Text] [Related]  

  • 29. VIP binding sites in adult rat hypothalamus: nuclear distribution and daily variations.
    Morin AJ; Moyse E; Denoroy L; Jouvet M
    Peptides; 1994 Jan; 15(1):117-23. PubMed ID: 8015968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characterization of vasoactive intestinal peptide receptors on rat alveolar macrophages.
    Sakakibara H; Shima K; Said SI
    Am J Physiol; 1994 Sep; 267(3 Pt 1):L256-62. PubMed ID: 7943252
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of binding sites for VIP-related peptides and activation of adenylate cyclase in developing pancreas.
    Le Meuth V; Farjaudon N; Bawab W; Chastre E; Rosselin G; Guilloteau P; Gespach C
    Am J Physiol; 1991 Feb; 260(2 Pt 1):G265-74. PubMed ID: 1847591
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An experimental study on brain-gut peptide receptors in brains of rats with hepatic encephalopathy].
    Zhang ZM; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 1994 Nov; 32(11):643-6. PubMed ID: 7774399
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The polypeptide PHI discriminates a GTP-insensitive form of VIP receptor in liver membranes.
    Pineau N; Lelievre V; Goursaud S; Hilairet S; Waschek JA; Janet T; Muller JM
    Neuropeptides; 2001 Apr; 35(2):117-26. PubMed ID: 11384207
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacology and molecular identification of vasoactive intestinal peptide (VIP) receptors in normal and cancerous gastric mucosa in man.
    Gespach C; Bawab W; Chastre E; Emami S; Yanaihara N; Rosselin G
    Biochem Biophys Res Commun; 1988 Mar; 151(2):939-47. PubMed ID: 2831906
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Distribution and characterization of vasoactive intestinal polypeptide binding in canine lower esophageal sphincter.
    Mao YK; Wang YF; Daniel EE
    Gastroenterology; 1993 Nov; 105(5):1370-7. PubMed ID: 8224641
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in the goose cerebral cortex.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Pol J Pharmacol; 2004; 56(2):203-11. PubMed ID: 15156071
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesotocin binding to receptors in hen kidney plasma membranes.
    Takahashi T; Kawashima M; Yasuoka T; Kamiyoshi M; Tanaka K
    Poult Sci; 1996 Jul; 75(7):910-4. PubMed ID: 8966180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evidence that vasoactive intestinal polypeptide is a physiological prolactin-releasing factor in the bantam hen.
    Macnamee MC; Sharp PJ; Lea RW; Sterling RJ; Harvey S
    Gen Comp Endocrinol; 1986 Jun; 62(3):470-8. PubMed ID: 3770438
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of GTP analogs and dithiothreitol on the binding properties of the vascular vasoactive intestinal peptide receptor.
    Huang M; Rorstad OP
    Can J Physiol Pharmacol; 1989 Aug; 67(8):851-6. PubMed ID: 2557141
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel cyclic peptide agonist of high potency and selectivity for the type II vasoactive intestinal peptide receptor.
    Xia M; Sreedharan SP; Bolin DR; Gaufo GO; Goetzl EJ
    J Pharmacol Exp Ther; 1997 May; 281(2):629-33. PubMed ID: 9152366
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.